Daniel G. Billen's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 5,252 Common Stock done at an average price of $5.7 . Disclosure was reported to the exchange on May 21, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc | Daniel G. Billen | Director | Sale of securities on an exchange or to another person at price $ 5.74 per share. | 21 May 2024 | 5,252 | 28,141 (0%) | 0% | 5.7 | 30,146 | Common Stock |
| Aurinia Pharmaceuticals Inc | Daniel G. Billen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 15,234 | 15,234 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Daniel G. Billen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 9,310 | 38,043 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharmaceuticals Inc | Daniel G. Billen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 8,733 | 28,733 (0%) | 0% | - | Common Stock | |
| Aurinia Pharmaceuticals Inc | Daniel G. Billen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 8,733 | 0 | - | - | Restricted Stock Units | |
| Aurinia Pharmaceuticals Inc | Daniel G. Billen | Director | Sale of securities on an exchange or to another person at price $ 11.26 per share. | 18 May 2023 | 4,650 | 33,393 (0%) | 0% | 11.3 | 52,359 | Common Stock |
| Aurinia Pharmaceuticals Inc | Daniel G. Billen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 14,612 | 14,612 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Daniel G. Billen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,733 | 8,733 | - | - | Restricted Stock Unit | |
| Aurinia Pharmaceuticals Inc | Daniel G. Billen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 31,347 | 31,347 | - | - | Stock Option (right to buy) |